Law Offices of Thomas J. Lamb

  • About Our Firm
  • Drug Injury
  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Breast Implants
  • Free Case Evaluation
  • FAQs

Elmiron Legal Cases for Eye Damage and Retinal Injury Are Consolidated in Elmiron MDL

January 15, 2021 By Law Offices of Thomas J. Lamb, P.A.

In December 2020, all Elmiron legal cases alleging eye damage and retinal injury filed in the federal courts were consolidated by means of an Elmiron MDL Order. These Elmiron legal cases are noteworthy as regards the monetary damages aspect of a lawsuit because these Elmiron-related eye problems can lead to vision loss or blindness. From the … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Elmiron, pigmentary maculopathy, retinal maculopathy, vision loss

Beovu: What Comes Next for This Troubled Novartis AMD Eye Injection?

January 11, 2021 By Law Offices of Thomas J. Lamb, P.A.

As we start 2021, let’s look at where things currently stand with the Beovu “safety issue” — Beovu adverse drug reactions and Beovu-related eye problems — and how we got here. In the 15 months since Beovu was approved by the FDA in October 2019, there have been numerous reports of Beovu causing occlusive retinal vasculitis, retinal artery … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal artery occlusion, retinal vascular occlusion, retinal vasculitis, vision loss

Elmiron Updates: Legal, Medical, and Regulatory – December 2020

January 5, 2021 By Law Offices of Thomas J. Lamb, P.A.

In our final Drug Injury Watch article for 2020 we want to report on the recent developments regarding Elmiron lawsuits, Elmiron side effects warnings, and Elmiron pigmentary maculopathy diagnosis methods. As regards the increasing number of Elmiron lawsuits for patients who have suffered vision loss due to Elmiron pigmentary maculopathy, there … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Elmiron, pigmentary maculopathy, vision loss

Beovu Retinal Vasculitis Made Worse by a Later Lucentis Treatment

December 21, 2020 By Law Offices of Thomas J. Lamb, P.A.

A recent medical journal article presents an interesting case report about a 76-year-old woman with Beovu-related retinal vasculitis which was made worse by a later Lucentis treatment for her wet AMD. That patient's doctors are the authors of "Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal vasculitis, vision loss

Beovu-related Retinal Vasculitis and Beovu Vision Loss Cases

December 11, 2020 By Law Offices of Thomas J. Lamb, P.A.

As of December 2020, the investigation continues to find the root causes of Beovu-related retinal vasculitis which seems to be involved in many of the growing numbers of Beovu vision loss cases. At the same time retina specialists and other eye doctors are still trying to determine the best medical management or treatment methods for Beovu patients … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, occlusive retinal vasculitis, retinal vasculitis, vision loss

Beovu Injections Side Effects: Novartis Points Out Risk Factors and Possible Causes in November 2020 Report

November 19, 2020 By Law Offices of Thomas J. Lamb, P.A.

In mid-November 2020 Novartis addressed the root causes and potential risk factors for Beovu patients developing vision loss by releasing some findings by its experts examining these adverse events associated with Beovu injections. From this November 14, 2020, Reuters new report, “Novartis identifies possible risk factors for Beovu … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, retinal vascular occlusion, retinal vasculitis, vision loss

Beovu Legal Cases: Compensation for Eye Problems from Beovu Use

November 3, 2020 By Law Offices of Thomas J. Lamb, P.A.

Our law firm is investigating possible Beovu lawsuits for patients who have been diagnosed with vision loss, blindness, or other serious eye problems which are Beovu side effects. Such drug injury Beovu legal cases might involve one or more of the following Beovu eye-related side effects: Vision LossBlindnessOcclusive Retinal VasculitisRetinal … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, eye inflammation, occlusive retinal vasculitis, retinal vasculitis, vision loss

Beovu-associated Endophthalmitis is “New” for Beovu Eye Drug Safety Issue of Vision Loss

October 8, 2020 By Law Offices of Thomas J. Lamb, P.A.

In this article, we will look at the Beovu-associated endophthalmitis and Beovu-associated retinal detachment aspects of the Beovu eye drug safety issue of vision loss. New warnings for these vision-related side effects were added in June 2020 when Novartis revised the Prescribing Information for Beovu. In the Beovu drug label, or “Full … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, endophthalmitis, intraocular inflammation, occlusive vasculitis, retinal detachment, vision loss

Beovu Use Continues Despite Ongoing Beovu-associated Inflammation Investigation

October 2, 2020 By Law Offices of Thomas J. Lamb, P.A.

A summary of the Beovu-associated inflammation safety issue is presented in this July 2020 Journal of VitreoRetinal Diseases Research Article, “Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab”. From the Abstract for this item we get these details about the current Beovu safety issue under investigation: Conclusions: … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, occlusive retinal vasculitis, retinal artery occlusion, vision loss

Safety of Beovu Update: Study Results Announcement by Novartis and Beovu Label Change in Europe

September 24, 2020 By Law Offices of Thomas J. Lamb, P.A.

A September 2020 announcement by Novartis about recent Beovu study results had an emphasis on the safety of Beovu. However, this is understandable in view of a February 2020 notification issued by the American Society of Retina Specialists (ASRS) which raised questions about the safety of Beovu. We get the following from this September 14, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Beovu, blindness, intraocular inflammation, retinal vascular occlusion, retinal vasculitis, vision loss

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • Drug Injury Cases
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • GenX Cancer Cases
  • Breast Implant Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • About Our Firm
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2021 · Law Offices of Thomas J. Lamb, P.A.